Please login to the form below

Not currently logged in
Email:
Password:

Daiichi sets up new vaccine research unit

Japanese pharma company establishes new research facility at its Kasai R&D Center in Tokyo

Daiichi Sankyo has set up a new vaccine research unit in Tokyo as part of a drive to expand its R&D in infectious diseases.

The unit will be located in the Japanese pharma company's Kasai R&D Center at Edogawa-ku, Tokyo and focus on making pharmacological assessments for vaccines, including the immunogenicity of candidate antigens and their ability to fend off infection.

Daiichi has been expanding its vaccine business of late, and in April this year set up an exploratory vaccine research unit within the Osaka-based National Institute of Biomedical Innovation.

This unit is already performing exploratory vaccine research and "continuously reinforcing and expanding R&D for new adjuvants," the company said.

It added: "Now, with two vaccine research units and partnerships with organisations inside and outside of the Group, Daiichi Sankyo is poised to fully realise its dedication to producing new vaccines through continuing research efforts and to supplying safe and effective existing vaccines to the healthcare professionals and other persons in Japan who are waiting for them."

Daiichi's domestic subsidiary Kitasato Daiichi Sankyo Vaccine Co. was recently forced to delay supplying its influenza HA vaccine and vaccine syringe to the Japanese market after some batches failed to meet quality standards.

Shipments of the vaccine resumed at the end of last month, but only half of the 4.8 million dose supply met Daiichi's quality specification and the company aims to ramp up production in order to supply an additional 1.2 million doses from the beginning of January 2012.

1st November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics